SFPIM
VC Fund
Brussel, Belgium
SFPIM is a VC fund in Brussel focused on Biotechnology and Health Care. SFPIM investment firm that invests in technology and infrastructure.
- Total investments:
- 26
- Last investment:
- Lead investor:
- 31%
Last updated:
For AI agents: llms.txt
Industries SFPIM invests in
BiotechnologyHealth CareSemiconductorAgTechAgriculture
Stages SFPIM invests in
Series AVenture - Series UnknownFunding RoundSeries BSeed
Countries SFPIM invests in
BelgiumFranceSwitzerland
Round sizes
Series A $8.6M–$57MVenture - Series Unknown $11M–$251M
Round size
- Series A
- $8.6M–$57M
- Venture - Series Unknown
- $11M–$251M
Investment Focus
Industry
- Biotechnology 9 (35%)
- Health Care 6 (23%)
- Semiconductor 4 (15%)
- AgTech 3 (12%)
- Agriculture 3 (12%)
Stage
- Series A 11 (42%)
- Venture - Series Unknown 5 (19%)
- Funding Round 3 (12%)
- Series B 2 (8%)
- Seed 1 (4%)
Country
- Belgium 22 (85%)
- France 1 (4%)
- Switzerland 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| e-peas is a disruptive semiconductor company that enables the seamless operation of all connected nodes. The company is developing ultra-low-power high performances circuits such as energy harvester interfaces and microcontrollers that help companies make their IoT devices smarter and more energy-efficient by either prolonging battery life ormaking the devices live forever. e-peas also develops energy harvesting solutions which extend rechargeable batteries' life of portable devices by harvesting energy from solar, thermal, vibration, radiofrequency, and other sources. These solutions help industries to build products that free users and industries from a burden of replacing non-rechargeable batteriesThe company was founded in 2014 and is headquartered in Mont-saint-guibert, Brabant Wallon, Belgium. | $21.9M / Venture - Series Unknown / Jul 08, 2026 | ||
| D-CRBN Operator of a climate technology company that aims to transform carbon into sustainable raw resources. | $20.4M / Series A / May 26, 2026 | ||
| Biotalys is an Agricultural Technology (AgTech) company that employs its proprietary Agrobody technology platform to develop crop and food protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combinethe high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications.It was incorporated in 2013 and is based in the Biotech hub in Ghent, Belgium. | $14.1M / Post-IPO Equity / May 06, 2026 | ||
| BanqUP is an API-driven platform for open banking solutions, allowing for banks and fintech companies to access a number of European banking APIs. BanqUP helps TPPs and banks quickly access open banking ecosystem and analyze banking data, allowing them to create bold and innovative solutions, as well as cross-sell and up-sell their existingproducts. | $6.5M / Debt Financing / Jan 26, 2026 | ||
| Aidoptation develops autonomous driving technology for dual-use applications in commercial automotive, police and first-responder vehicles, and defence-relevant environments. | $23.4M / Series A / Dec 19, 2025 | ||
| Resortecs leads the circular transition in fashion with Design for Disassembly. We empower brands, sorters, and recyclers with heat-dissolvable stitching threads and thermal disassembly systems that make recycling easy. Through targeted innovations in the way textile products are assembled and disassembled, we help fashion players rise totoday’s environmental challenges at the pace and scale Earth needs. All without compromising the creativity, design, and quality of clothing.Resortecs' thermal disassembly solution is five times faster than traditional disassembly methods and makes it possible to recycle up to 90% of the original fabric material: • Smart Stitch™, our heat-dissolvable stitching thread with different melting points (150 °C, 170 °C and 190 °C), enables brands to transform their products into recyclable, circular pieces from the manufacturing stage. • Smart Disassembly™, our thermal disassembly system, enables recyclers to unlock higher volumes of premium-quality material, processing up to 4M garments/year with low emissions and no material damage so that fabrics can be used over and over again. Welcome to sustainability's next level: circularity. | $6.9M / Series A / Nov 18, 2025 | ||
| MRM Health NV, is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome. MRM Health was incorporated early 2020 by MRM Technologies, a Center of Expertise for microbiome research based in the biotech cluster in Ghent, in a joint venture with the Flemish Institute ofBiotechnology (VIB), an excellence-based entrepreneurial life sciences research institute in Flanders, Belgium, that focuses on translating basic scientific results into pharmaceutical, agricultural and industrial applications. | $64.1M / Series B / Sep 04, 2025 | ||
| Wooclap is an online polling system that makes your classes, conferences and training sessions more fun and effective. Used in more than 150+ countries, the solution is used by large accounts, universities / colleges and departments.Rather than fighting smartphones, Wooclap turns them into an exceptional learning tool. Through questionnairesand other animations, the solution allows the teacher to realize the degree of understanding of the participants in real time. The solution is simple, intuitive and intuitive for both the teacher and the participants. In three stages, Wooclap allows you to transform the way you communicate with your learners.Create your questions (multiple choice questions, polls, numerical value questions, link two columns, word clouds, etc.) Launch your question and invite your learners to connect to the URL displayed on the screen. Collect real-time responses from your learners and interact with them based on the answers. | $29.1M / Sep 04, 2025 | ||
| John Cockerill Hydrogen is a major global company that specializes in green hydrogen technology, particularly innovative alkaline electrolysers used to produce hydrogen. | $134.7M / Jun 24, 2025 | ||
| Sequana Medical is a Swiss medical device company providing implantable pump systems to manage fluid balance within the body. This system is designed to move excess fluid to the bladder, where it is passed naturally from the body through normal urination.Sequana Medical’s first product, the Alfapump System, is an innovative solution for themanagement of ascites. Ascites is a fluid that collects in the abdominal cavity in people with advanced liver disease, certain cancers, or congestive heart failure. Alfapump System was the first and only system for the automatic and continual removal of ascites.Sequana Medical was founded in 2006 and is based in Zurich, Switzerland. | $7.1M / Post-IPO Debt / May 27, 2025 | ||
| See all 26 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
Health Care Investors
48,627 investors
Hardware Investors
46,079 investors
Biotech Investors
24,131 investors
Biotechnology Investors
21,397 investors
Agriculture (agtech) Investors
11,556 investors
Health Care VC Funds
36,465 investors
Hardware VC Funds
35,504 investors
Biotech VC Funds
20,850 investors
Biotechnology VC Funds
18,763 investors
FAQ
What does SFPIM invest in?
SFPIM invests primarily in Biotechnology, Health Care and Semiconductor startups, most often at Series A and Venture - Series Unknown stage. Most of the 26 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is SFPIM's check size?
SFPIM typically joins rounds of $8.6M–$57M at Series A and $11M–$251M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds SFPIM participates in.
When did SFPIM last invest?
The most recent investment recorded for SFPIM closed in Jul 2026. Shizune tracks 26 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
